Oragenics (OGEN) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Valion Bio is the larger company by market cap ($4.3 million vs $2.1 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OGEN | VBIO |
|---|---|---|
| Share price | $0.463 | $2.20 |
| Market cap | $2.09M | $4.28M |
| 1-day change | 0.00% | -0.45% |
| EPS (TTM) | $-2.44 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.45 | $76.50 |
| 52-week low | $0.46 | $2.05 |
| Distance from 52-week high | -68.07% | -97.12% |
| Average volume | 29.43K | 1.46M |
| Shares outstanding | 4.51M | 1.95M |
| Employees | 3 | 52 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Valion Bio is about 2.0 times larger than Oragenics by market value ($4.28M vs $2.09M).
About Oragenics
OGEN stock →Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Valion Bio
VBIO stock →Valion Bio, Inc. operates as a late-stage biopharmaceutical company.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 52 employees
OGEN vs VBIO FAQ
Which is bigger, Oragenics or Valion Bio?
Valion Bio (VBIO) is larger, with a market capitalization of $4.28M compared with $2.09M for Oragenics (OGEN).
Are Oragenics and Valion Bio in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Oragenics and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Valion Bio.